JUNE 6, 2018

Company

GYRE THERAPEUTICS, INC.

Filed

June 11, 2018

Accession Number

0001013594-18-000381

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →